A 22-year-old woman presents with a two-week history of fatigue, bleeding from her gums, and very heavy menstrual bleeding. Physical examination reveals a pale woman with enlarged spleen and petechiae on her legs. A complete blood cell count shows marked elevated white blood cell count. What is the diagnosis?

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
I now have excellent source material to give a thorough answer. Here is the full response:

Diagnosis: Acute Leukemia (most likely Acute Myeloid Leukemia, AML)

This patient's presentation is a textbook case of acute leukemia. Let's break down how each finding points to the diagnosis:

Connecting the Dots

Clinical FindingPathophysiologic Explanation
Fatigue, pallorAnemia from bone marrow infiltration by blasts (cytopenias)
Gum bleeding, heavy menstrual bleeding, petechiaeThrombocytopenia - blasts crowd out normal platelet-producing megakaryocytes
SplenomegalyExtramedullary infiltration of the reticuloendothelial system by leukemic cells
Markedly elevated WBCMassive proliferation of malignant blast cells (leukocytosis/hyperleukocytosis)
Age 22, femaleBoth AML and ALL affect young adults; ALL peaks 3-5 years in children, AML becomes more common with age
As stated in Tintinalli's Emergency Medicine: "Cytopenias from marrow infiltration can present as pallor, easy bleeding/bruising with petechiae and ecchymoses, infections, or bone pain. The reticuloendothelial system is the most common site of extramedullary infiltration, manifesting as hepatomegaly, splenomegaly, and/or lymphadenopathy."

Why AML vs. ALL?

While both are possible, AML is more likely here given:
  • Hyperleukocytosis (markedly elevated WBC) is more commonly associated with AML
  • Gingival/mucosal bleeding is characteristic of AML - gum infiltration (leukemia cutis/gingiva) is a hallmark of AML, especially the monocytic subtypes (M4/M5)
  • Heavy menstrual bleeding strongly suggests significant thrombocytopenia and possibly DIC (disseminated intravascular coagulation), which is classically associated with AML-M3 (Acute Promyelocytic Leukemia, APL) - a critical subtype to consider
AML-M3 (APL) deserves special mention: It is particularly associated with life-threatening bleeding due to DIC and should be considered an emergency. It is treated with all-trans retinoic acid (ATRA) + arsenic trioxide.

Diagnostic Criteria

The diagnosis of AML requires ≥20% blasts in the bone marrow or peripheral blood (WHO classification). Workup should include:
  1. CBC with differential and peripheral blood smear - look for blast cells, often showing Auer rods (pathognomonic for AML)
  2. Bone marrow aspirate and biopsy - definitive diagnosis; blast percentage, morphology
  3. Immunophenotyping (flow cytometry) - myeloid markers: MPO, CD13, CD33, CD117
  4. Cytogenetics and molecular studies - e.g., t(15;17) in APL, FLT3 and NPM1 mutations in AML
  5. Coagulation profile (PT, aPTT, fibrinogen, D-dimer) - screen for DIC
  6. Serum chemistries - LDH, uric acid, electrolytes (tumor lysis risk)

Summary

The diagnosis is Acute Leukemia, and with this specific constellation (young woman, mucosal/uterine bleeding, splenomegaly, markedly elevated WBC), Acute Myeloid Leukemia (AML) is the leading diagnosis - with Acute Promyelocytic Leukemia (APL/AML-M3) being the most urgent subtype to rule out due to its associated life-threatening coagulopathy.
  • Tintinalli's Emergency Medicine: A Comprehensive Study, Clinical Features of Acute Leukemia
  • Henry's Clinical Diagnosis and Management by Laboratory Methods, Acute Myeloid Leukemia
This is a shared conversation. Sign in to Orris to start your own chat.